Share

News Updates: Diagnostics

Genzyme and NORD Establish Patient Assistance Program to Help Undiagnosed Patients with Rare Diseases

Posted by Kerrie Denner

Genzyme, a Sanofi company, and the National Organization for Rare Disorders (NORD) today announced the creation of a fund to pay for standard diagnostic testing for people with mysterious, undiagnosed medical conditions.  The fund will help those who have applied to the National Institutes of Health (NIH) Undiagnosed Diseases Program, but who cannot afford the basic medical tests needed to make them eligible to participate in the NIH program.

Pages

Did this information help you? 

 

Join VEDA's email list to receive the latest news & updates! 

Sign me up! No, thanks